Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Teams With Wisconsin Partners in Cardiovascular Disease Prevention Program

NEW YORK, Aug. 6-Third Wave Technologies is partnering with a Wisconsin health care provider and a Milwaukee clinical bioinformatics company to offer genetics-based preventive treatment of cardiovascular disease, the companies said today.


In the partnership, software from the bioinformatics company PointOne will first be used to screen Aurora Health Care's 72,000 cardiovascular patients for risk of deep vein thrombosis.


This initial screen will flag patients that may benefit from additional testing. Third Wave will then use genetic screening to test that group for two genetic variations associated with DVT. Those identified at particularly high risk can be treated with anti-clotting drugs or lifestyle modifications.


Third Wave's genetic tests will also be used to help Aurora Health Care physicians judge which patients should be treated with drugs, and choose the dosages of these medications.


In DVT, blood forms clots in the leg veins and can travel to the heart or lung with fatal results. Many cases result from surgery or prolonged illness.


Third Wave Technologies is a gene analysis equipment and service company based in Madison, Wis. Aurora Health Care is a non-profit Wisconsin health care network based in Milwaukee.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.